The Venous Center

Filter Your Results




European Guidelines Address Management of the Diseases of Mesenteric Arteries and Veins

March 28, 2017 -- Clinical practice guidelines of the European Society of Vascular Surgery (ESVS) addressing management of the diseases of mesenteric arteries and veins has be…

Q3 Medical Financing Agreement to Support Product Development and Commercialization

March 15, 2017 -- Q3 Medical Devices Limited announced that it has entered into an €28.3-million investment agreement with Boill Holding Group of Shanghai, China. Th…

Office-Based Lab Models: Getting Started

With Donald S. Cross, MD, FACC; Alberto Gonzalez, MD, FACS; and Kenneth J. Wright, MD, FACS

March 2017— The first in a four-part series in which we take an in-depth look at the development and key issues related to office-based labs (OBLs) from the perspective of physicians wh…

The Joint Venous Consortium: Rationale and Proposed Goals

Jose I. Almeida, MD, FACS; Steve Elias, MD, FACS; and Neil M. Khilnani, MD

March 2017—Maximizing the doctor/patient relationship through education and oversight.

Five Must-Read Superficial Venous Publications

Peter F. Lawrence, MD

March 2017—Use of the Clinical, Etiologic, Anatomic, and Pathophysiologic Classification and Venous Clinical Severity Score to Establish a Treatment Plan for Chronic Venous Disorders …

Expert Opinions on Hot Topics in Endovenous Therapy

With Sergio Gianesini, MD; Ian Franklin, MBBS, MS, FRCS(Gen Surg); Evgeny Shaydakov, MD, PhD; and Patrick E. Muck, MD

March 2017—Following the recent 2017 American Venous Forum meeting, we asked key opinion leaders from the United States and abroad their thoughts on some of the most discussed issues that continue to be debated.

Double-Blind Study Compares Angioplasty to Sham to Treat CCSVI in MS

March 8, 2017 -- The University of British Columbia (UBC) announced findings from a study showing that venoplasty to open narrowed veins from the brain and spinal cord is…

2-Year ATTRACT Data: Anticoagulation Alone Best for Most DVT; PCDT Benefits Seen in Certain Iliofemoral Patients

March 6, 2017 -- The much-anticipated 2-year results from the ATTRACT study were presented by Suresh Vedantham, MD, FSIR, on behalf of the trial’s investigators, at the …




Contact Info

For advertising rates and opportunities, contact:
Craig McChesney

Stephen Hoerst

Charles Philip

About Endovascular Today

Endovascular Today is a publication dedicated to bringing you comprehensive coverage of all the latest technology, techniques, and developments in the endovascular field. Our Editorial Advisory Board is composed of the top endovascular specialists, including interventional cardiologists, interventional radiologists, vascular surgeons, neurologists, and vascular medicine practitioners, and our publication is read by an audience of more than 22,000 members of the endovascular community.